71 related articles for article (PubMed ID: 17105420)
1. Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?
Berghella AM; Contasta I; Pellegrini P; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):468-87. PubMed ID: 17105420
[TBL] [Abstract][Full Text] [Related]
2. The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.
Pellegrini P; Berghella AM; Contasta I; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):443-67. PubMed ID: 17105419
[TBL] [Abstract][Full Text] [Related]
3. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression.
Pellegrini P; Berghella AM; Del Beato T; Cicia S; Adorno D; Casciani CU
Cancer Immunol Immunother; 1996 Jan; 42(1):1-8. PubMed ID: 8625361
[TBL] [Abstract][Full Text] [Related]
4. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
5. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
6. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Contasta I; Berghella AM; Pellegrini P; Adorno D
Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
[TBL] [Abstract][Full Text] [Related]
7. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.
Contasta I; Pellegrini P; Berghella AM; Del Beato T; Adorno D
Cancer Biother Radiopharm; 2006 Oct; 21(5):488-505. PubMed ID: 17105421
[TBL] [Abstract][Full Text] [Related]
9. A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth.
Hou N; Zhang X; Zhao L; Zhao X; Li Z; Song T; Huang C
Biochem Biophys Res Commun; 2013 Oct; 439(4):471-6. PubMed ID: 24036270
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
11. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
15. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
16. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
17. Can we apply the TH1-TH2 paradigm to all lymphocytes?
Colonna M
Nat Immunol; 2001 Oct; 2(10):899-900. PubMed ID: 11577341
[No Abstract] [Full Text] [Related]
18. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells.
Fujibayashi Y; Fujimori Y; Kasumoto I; Kai S; Hara H; Okamura H; Tsutsui H; Ogawa H; Nakanishi K
Int J Mol Med; 2007 Aug; 20(2):241-5. PubMed ID: 17611643
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
20. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
